miRagen Therapeutics

miRagen Therapeutics (NASDAQ: MGEN) is harnessing the power of microRNA science to develop therapies that normalize biological pathways and counterbalance disease.

Headquarters Boulder, CO
Website www.miragen.com​
Twitter @miRagenRx​
Pipeline Phase 1 clinical trials
Partners Servier